NVIDIA
NVDA
Tesla
TSLA
Intel
INTC
Disney
DIS
Micron Technology
MU
US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 25.150
- -0.850-3.27%
Close Feb 28 16:00 ET
- 26.000
- +0.850+3.38%
Post 20:01 ET
3.16BMarket Cap-15.72P/E (TTM)
26.050High24.330Low2.96MVolume26.000Open26.000Pre Close74.26MTurnover3.51%Turnover RatioLossP/E (Static)125.52MShares66.00052wk High13.81P/B2.12BFloat Cap24.33052wk Low--Dividend TTM84.21MShs Float94.750Historical High--Div YieldTTM6.62%Amplitude11.450Historical Low25.102Avg Price1Lot Size
About Apellis Pharmaceuticals Company
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Company Profile
SymbolAPLS
Company NameApellis Pharmaceuticals
Listing DateNov 9, 2017
Issue Price14.00
Founded2009
CEODr. Cedric Francois, M.D.
MarketNASDAQ
Employees706
Fiscal Year Ends12-31
Address100 5th Avenue
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451-8703
Phone1-617-977-5700
Websitehttp://www.apellis.com
Company Executives
- Name
- Position
- Salary
- Dr. Cedric Francois, M.D.
- Director, Chief Executive Officer and President
- 10.37M
- Dr. Caroline Baumal, M.D.
- Chief Medical Officer
- 4.43M
- Nur Nicholson
- Chief Technical Operations Officer
- --
- Timothy E. Sullivan
- Chief Financial Officer and Treasurer
- 3.74M
- Mark Jeffrey DeLong
- Chief Business and Strategy Officer
- --
- James George Chopas
- Vice President, Corporate Controller and Chief Accounting Officer
- --
- Karen Lewis
- Chief People Officer
- --
- Pascal Deschatelets, PhD
- Chief Scientific Officer
- --
- Dr. Jeffrey Eisele, PhD
- Chief Development Officer
- --
- David Acheson
- Executive Vice President, Commercial
- --
- Dr. Gerald L. Chan, Sc.D.
- Chairman of the Board
- 504.08K
- Stephanie Monaghan O’Brien
- Independent Director
- 488.46K
- Keli Walbert
- Independent Director
- --
- Paul Fonteyne, M.S.
- Independent Director
- 489.08K
- Alec Machiels
- Independent Director
- 495.96K
- A. Sinclair Dunlop
- Independent Director
- 480.96K
- David Watson
- General Counsel
- 4.89M
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
